Andreas Martin Kany

22PUBLICATIONS
84CO-AUTHORS
Micro- and nanosystemsPharmaceutical delivery technologiesMolecular targetsMedical infection agents (incl. prions)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 22, 2026
Generative AI designs functional thiolation domains for reprogramming non-ribosomal peptide synthetases.

|Feb 05, 2026
Multiparameter Optimization of Pseudomonas aeruginosa Elastase Inhibitors for Systemic Administration.

Ahmed S Abdelsamie, Jelena Konstantinović, Andreas M Kany

|Nov 18, 2025
Toward Anti-Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen.

Aylin Berwanger, Saskia Catherina Stein, Sarah Brandner

|Feb 20, 2025
Dipeptidic Phosphonates: Potent Inhibitors of Pseudomonas aeruginosa Elastase B Showing Efficacy in a Murine Keratitis Model.

Alexander F Kiefer, Christian Schütz, Colya N Englisch

|Oct 24, 2024
Structure Revision of Halisphingosine A via Total Synthesis and Bioactivity Studies.

Maria Sauer, Andreas M Kany, Sebastian Götze

|Sep 20, 2024
Targeting Plasmodium falciparum IspD in the Methyl-d-erythritol Phosphate Pathway: Urea-Based Compounds with Nanomolar Potency on Target and Low-Micromolar Whole-Cell Activity.

Daan Willocx, Lorenzo Bizzarri, Alaa Alhayek

Pageof 4

Frequent Collaborators

16 joint publications

Anna Katharina Herta Hirsch

7 joint publications

Rolf Wolfgang Hartmann

6 joint publications

Jörg Haupenthal

6 joint publications

Rolf Müller